The cardiovascular monitoring and diagnostic devices and equipment market size has grown strongly in recent years. It will grow from $4.12 billion in 2025 to $4.34 billion in 2026 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, expansion of hospital diagnostic capabilities, increased use of ecg monitoring technologies, growing awareness of preventive cardiac care, availability of advanced diagnostic devices.
The cardiovascular monitoring and diagnostic devices and equipment market size is expected to see steady growth in the next few years. It will grow to $5.13 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing demand for home-based cardiac monitoring, rising adoption of ai-assisted diagnostics, expansion of telecardiology services, growing investments in digital healthcare infrastructure, continuous innovation in non-invasive monitoring technologies. Major trends in the forecast period include increasing adoption of remote cardiac monitoring systems, rising use of wearable ecg devices, growing integration of cloud-based data management platforms, expansion of continuous and wireless monitoring solutions, enhanced focus on early disease detection.
The cardiovascular monitoring and diagnostic devices and equipment market is being driven by the rising number of individuals affected by obesity and diabetes. Risk factors associated with these conditions, including high blood pressure and elevated cholesterol, contribute to cardiovascular disease. For example, according to a study by the American Heart Association (AMA), the prevalence of CVD is projected to reach 22.2 million by 2030. Another AMA study indicates that in the U.S., 26 million people have been diagnosed with diabetes, while over 9 million more have the condition but remain undiagnosed.
Leading companies in the cardiovascular monitoring and diagnostic devices and equipment market are developing innovative solutions such as the LUX-Dx II+ insertable cardiac monitor (ICM) system to improve patient care. The LUX-Dx II+ is a next-generation ICM designed to provide physicians with enhanced diagnostic evaluation and long-term monitoring for individuals experiencing irregular heartbeats. For instance, in October 2023, Boston Scientific, a U.S.-based medical device manufacturer, launched the LUX-Dx II+ system. It features dual-stage algorithms, high-quality S-ECG signals, remote programming capabilities, wireless connectivity, a patient app, and a compact design, offering clinicians a sophisticated tool for cardiovascular monitoring and diagnosis.
In May 2024, WearLinq Inc., a U.S.-based provider of digital healthcare solutions, acquired AMI Cardiac Monitoring LLC for an undisclosed amount. This acquisition strengthens WearLinq’s position in the ambulatory cardiac monitoring market by expanding access to its FDA-cleared eWave 6-lead ECG monitor nationwide and integrating AMI’s clinical diagnostic expertise. The deal enhances the company’s cardiovascular diagnostics capabilities by combining advanced wearable monitoring technology with established Medicare-certified diagnostic services. AMI Cardiac Monitoring LLC is a U.S.-based privately held company specializing in cardiovascular monitoring and diagnostic equipment.
Major companies operating in the cardiovascular monitoring and diagnostic devices and equipment market are Medtronic PLC, Boston Scientific Corporation, GE Healthcare, Philips Healthcare, Siemens Healthcare, St. Jude Medical Inc., Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., Sorin Group, Welch Allyn Inc., LivaNova PLC, Spacelabs Healthcare, Opto Circuits India Ltd., BPL Health Management Solutions, OSI Systems Inc., Schiller AG, Abbott Cardiovascular, Aerotel Medical Systems Ltd., Dräger Medical AG & Co. KGaA, Biotronik Inc., Koninklijke Philips N.V., Endotronix Inc., Smartcardia, Ivy Biomedical Systems Inc., Cardio Diagnostics Holdings Inc., ECG Excellence BV, Aktiia SA, HD Medical, HeartFlow Inc., VPG Medical, BioTelemetry Inc., Preventice Solutions, Mortara Instrument Inc., Getemed Medizin-Und Informationstechnik AG, LifeWatch Technologies Ltd., QRS Diagnostic.
North America was the largest region in global cardiovascular monitoring and diagnostic devices and equipment market in 2025. Western Europe was the second-largest region in cardiovascular monitoring and diagnostic devices and equipment market. The regions covered in the cardiovascular monitoring and diagnostic devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular monitoring and diagnostic devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are influencing the cardiovascular monitoring and diagnostic devices market by increasing costs of imported sensors, semiconductors, wireless communication modules, software systems, and diagnostic hardware components. Healthcare providers in North America and Europe are most affected due to dependence on imported monitoring equipment, while Asia-Pacific faces pricing pressure on manufacturing and exports of diagnostic devices. These tariffs are raising procurement costs and slowing large-scale device deployments. At the same time, they are supporting domestic manufacturing, regional electronics sourcing, and development of locally produced cardiac monitoring solutions.
The cardiovascular monitoring and diagnostic devices and equipment market research report is one of a series of new reports that provides cardiovascular monitoring and diagnostic devices and equipment market statistics, including cardiovascular monitoring and diagnostic devices and equipment industry global market size, regional shares, competitors with a cardiovascular monitoring and diagnostic devices and equipment market share, detailed cardiovascular monitoring and diagnostic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular monitoring and diagnostic devices and equipment industry. This cardiovascular monitoring and diagnostic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiovascular monitoring and diagnostic devices are essential tools used in diagnosing, monitoring, and treating cardiovascular conditions.
The primary product categories in this market encompass cardiopulmonary stress testing systems, ECG data management systems, ECG monitoring equipment, ECG stress testing systems, event monitoring systems, and Holter monitoring systems. ECG monitoring equipment, for example, functions as an electronic tool to record the heart's electrical activity. These devices are utilized for specific conditions like heart disease and coronary heart disease. They find application across various sectors, including hospitals, physician clinics, emergency settings, and research and development purposes in settings such as clinical trials, universities, and CROs.
The cardiovascular monitoring and diagnostic devices and equipment market consist of sales of cardiopulmonary stress testing systems, electrocardiogram (ECG) data management systems, ECG monitoring equipment, ECG stress testing systems, event monitoring systems, and holter monitoring systems that are used for diagnosis and treatment of cardio diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The cardiovascular monitoring and diagnostic devices and equipment market size is expected to see steady growth in the next few years. It will grow to $5.13 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing demand for home-based cardiac monitoring, rising adoption of ai-assisted diagnostics, expansion of telecardiology services, growing investments in digital healthcare infrastructure, continuous innovation in non-invasive monitoring technologies. Major trends in the forecast period include increasing adoption of remote cardiac monitoring systems, rising use of wearable ecg devices, growing integration of cloud-based data management platforms, expansion of continuous and wireless monitoring solutions, enhanced focus on early disease detection.
The cardiovascular monitoring and diagnostic devices and equipment market is being driven by the rising number of individuals affected by obesity and diabetes. Risk factors associated with these conditions, including high blood pressure and elevated cholesterol, contribute to cardiovascular disease. For example, according to a study by the American Heart Association (AMA), the prevalence of CVD is projected to reach 22.2 million by 2030. Another AMA study indicates that in the U.S., 26 million people have been diagnosed with diabetes, while over 9 million more have the condition but remain undiagnosed.
Leading companies in the cardiovascular monitoring and diagnostic devices and equipment market are developing innovative solutions such as the LUX-Dx II+ insertable cardiac monitor (ICM) system to improve patient care. The LUX-Dx II+ is a next-generation ICM designed to provide physicians with enhanced diagnostic evaluation and long-term monitoring for individuals experiencing irregular heartbeats. For instance, in October 2023, Boston Scientific, a U.S.-based medical device manufacturer, launched the LUX-Dx II+ system. It features dual-stage algorithms, high-quality S-ECG signals, remote programming capabilities, wireless connectivity, a patient app, and a compact design, offering clinicians a sophisticated tool for cardiovascular monitoring and diagnosis.
In May 2024, WearLinq Inc., a U.S.-based provider of digital healthcare solutions, acquired AMI Cardiac Monitoring LLC for an undisclosed amount. This acquisition strengthens WearLinq’s position in the ambulatory cardiac monitoring market by expanding access to its FDA-cleared eWave 6-lead ECG monitor nationwide and integrating AMI’s clinical diagnostic expertise. The deal enhances the company’s cardiovascular diagnostics capabilities by combining advanced wearable monitoring technology with established Medicare-certified diagnostic services. AMI Cardiac Monitoring LLC is a U.S.-based privately held company specializing in cardiovascular monitoring and diagnostic equipment.
Major companies operating in the cardiovascular monitoring and diagnostic devices and equipment market are Medtronic PLC, Boston Scientific Corporation, GE Healthcare, Philips Healthcare, Siemens Healthcare, St. Jude Medical Inc., Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., Sorin Group, Welch Allyn Inc., LivaNova PLC, Spacelabs Healthcare, Opto Circuits India Ltd., BPL Health Management Solutions, OSI Systems Inc., Schiller AG, Abbott Cardiovascular, Aerotel Medical Systems Ltd., Dräger Medical AG & Co. KGaA, Biotronik Inc., Koninklijke Philips N.V., Endotronix Inc., Smartcardia, Ivy Biomedical Systems Inc., Cardio Diagnostics Holdings Inc., ECG Excellence BV, Aktiia SA, HD Medical, HeartFlow Inc., VPG Medical, BioTelemetry Inc., Preventice Solutions, Mortara Instrument Inc., Getemed Medizin-Und Informationstechnik AG, LifeWatch Technologies Ltd., QRS Diagnostic.
North America was the largest region in global cardiovascular monitoring and diagnostic devices and equipment market in 2025. Western Europe was the second-largest region in cardiovascular monitoring and diagnostic devices and equipment market. The regions covered in the cardiovascular monitoring and diagnostic devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular monitoring and diagnostic devices and equipment market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are influencing the cardiovascular monitoring and diagnostic devices market by increasing costs of imported sensors, semiconductors, wireless communication modules, software systems, and diagnostic hardware components. Healthcare providers in North America and Europe are most affected due to dependence on imported monitoring equipment, while Asia-Pacific faces pricing pressure on manufacturing and exports of diagnostic devices. These tariffs are raising procurement costs and slowing large-scale device deployments. At the same time, they are supporting domestic manufacturing, regional electronics sourcing, and development of locally produced cardiac monitoring solutions.
The cardiovascular monitoring and diagnostic devices and equipment market research report is one of a series of new reports that provides cardiovascular monitoring and diagnostic devices and equipment market statistics, including cardiovascular monitoring and diagnostic devices and equipment industry global market size, regional shares, competitors with a cardiovascular monitoring and diagnostic devices and equipment market share, detailed cardiovascular monitoring and diagnostic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular monitoring and diagnostic devices and equipment industry. This cardiovascular monitoring and diagnostic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiovascular monitoring and diagnostic devices are essential tools used in diagnosing, monitoring, and treating cardiovascular conditions.
The primary product categories in this market encompass cardiopulmonary stress testing systems, ECG data management systems, ECG monitoring equipment, ECG stress testing systems, event monitoring systems, and Holter monitoring systems. ECG monitoring equipment, for example, functions as an electronic tool to record the heart's electrical activity. These devices are utilized for specific conditions like heart disease and coronary heart disease. They find application across various sectors, including hospitals, physician clinics, emergency settings, and research and development purposes in settings such as clinical trials, universities, and CROs.
The cardiovascular monitoring and diagnostic devices and equipment market consist of sales of cardiopulmonary stress testing systems, electrocardiogram (ECG) data management systems, ECG monitoring equipment, ECG stress testing systems, event monitoring systems, and holter monitoring systems that are used for diagnosis and treatment of cardio diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Executive Summary
Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cardiovascular monitoring and diagnostic devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cardiovascular monitoring and diagnostic devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular monitoring and diagnostic devices and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Cardiopulmonary Stress Testing Systems; ECG Data Management Systems; ECG Monitoring Equipment; ECG Stress Testing Systems; Event Monitoring Systems; Holter Monitoring Systems2) By Disease Indication: Heart Disease; Coronary Heart Disease
3) By End-Use: Hospitals Or Physician Clinic (Continuous Glucose Monitors); Home Or Emergency; Research and Development (Clinical Trials; Universities; CRO)
Subsegments:
1) By Cardiopulmonary Stress Testing Systems: Treadmill Stress Testing Systems; Ergometer Stress Testing Systems; Respiratory Gas Exchange Systems; Other Cardiopulmonary Stress Testing Systems2) By ECG Data Management Systems: Cloud-Based ECG Data Management Systems; On-Premise ECG Data Management Systems; ECG Software For Data Analysis; Other ECG Data Management Systems
3) By ECG Monitoring Equipment: Continuous ECG Monitors; Wireless ECG Monitors; Handheld ECG Monitors; Other ECG Monitoring Equipment
4) By ECG Stress Testing Systems: Treadmill ECG Stress Testing Systems; Cycle Ergometer ECG Stress Testing Systems; Automated ECG Stress Testing Systems; Other ECG Stress Testing Systems
5) By Event Monitoring Systems: Mobile Event Monitors; Wireless Event Monitors; Holter Or Event Monitor Hybrid Systems; Other Event Monitoring Systems
6) By Holter Monitoring Systems: 24-Hour Holter Monitors; 48-Hour Holter Monitors; 7-Day Holter Monitors; Other Holter Monitoring Systems
Companies Mentioned: Medtronic PLC; Boston Scientific Corporation; GE Healthcare; Philips Healthcare; Siemens Healthcare; St. Jude Medical Inc.; Nihon Kohden Corporation; Fukuda Denshi Co. Ltd.; Sorin Group; Welch Allyn Inc.; LivaNova PLC; Spacelabs Healthcare; Opto Circuits India Ltd.; BPL Health Management Solutions; OSI Systems Inc.; Schiller AG; Abbott Cardiovascular; Aerotel Medical Systems Ltd.; Dräger Medical AG & Co. KGaA; Biotronik Inc.; Koninklijke Philips N.V.; Endotronix Inc.; Smartcardia; Ivy Biomedical Systems Inc.; Cardio Diagnostics Holdings Inc.; ECG Excellence BV; Aktiia SA; HD Medical; HeartFlow Inc.; VPG Medical; BioTelemetry Inc.; Preventice Solutions; Mortara Instrument Inc.; Getemed Medizin-Und Informationstechnik AG; LifeWatch Technologies Ltd.; QRS Diagnostic
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cardiovascular Monitoring and Diagnostic Devices and Equipment market report include:- Medtronic PLC
- Boston Scientific Corporation
- GE Healthcare
- Philips Healthcare
- Siemens Healthcare
- St. Jude Medical Inc.
- Nihon Kohden Corporation
- Fukuda Denshi Co. Ltd.
- Sorin Group
- Welch Allyn Inc.
- LivaNova PLC
- Spacelabs Healthcare
- Opto Circuits India Ltd.
- BPL Health Management Solutions
- OSI Systems Inc.
- Schiller AG
- Abbott Cardiovascular
- Aerotel Medical Systems Ltd.
- Dräger Medical AG & Co. KGaA
- Biotronik Inc.
- Koninklijke Philips N.V.
- Endotronix Inc.
- Smartcardia
- Ivy Biomedical Systems Inc.
- Cardio Diagnostics Holdings Inc.
- ECG Excellence BV
- Aktiia SA
- HD Medical
- HeartFlow Inc.
- VPG Medical
- BioTelemetry Inc.
- Preventice Solutions
- Mortara Instrument Inc.
- Getemed Medizin-Und Informationstechnik AG
- LifeWatch Technologies Ltd.
- QRS Diagnostic
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.34 Billion |
| Forecasted Market Value ( USD | $ 5.13 Billion |
| Compound Annual Growth Rate | 4.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 36 |
